| abstract |
The present invention relates to the treatment of corticotropin releasing factor (CRF) antagonists of Formula 1 or Formula 2, and anxiety, depression and other psychopathic neurological diseases, as well as immunological cardiovascular or heart related diseases and psychopathological diseases and stress And its use in the treatment of colonic hypersensitivity.n n n <Formula 1>n n n n n n n n <Formula 2> |